| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 36415 |
Collection of venous blood by venipuncture |
28,378 |
23,671 |
$5.25M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,803 |
4,401 |
$1.09M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,949 |
6,721 |
$1.00M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,333 |
7,481 |
$872K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,679 |
2,600 |
$859K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,776 |
1,632 |
$488K |
| 81003 |
|
12,316 |
11,175 |
$483K |
| 71046 |
Radiologic examination, chest; 2 views |
5,580 |
5,202 |
$469K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,677 |
3,355 |
$424K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,843 |
14,978 |
$416K |
| 99218 |
|
1,178 |
1,046 |
$372K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,318 |
2,201 |
$293K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,867 |
1,729 |
$202K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,614 |
2,304 |
$197K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
991 |
907 |
$178K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,715 |
2,493 |
$166K |
| 80053 |
Comprehensive metabolic panel |
15,791 |
14,018 |
$161K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,520 |
6,539 |
$155K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,505 |
1,392 |
$152K |
| 76830 |
Ultrasound, transvaginal |
557 |
544 |
$151K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,504 |
1,413 |
$140K |
| J3490 |
Unclassified drugs |
1,979 |
1,739 |
$127K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,306 |
969 |
$106K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,119 |
2,782 |
$99K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
472 |
457 |
$95K |
| 73630 |
|
726 |
687 |
$90K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
342 |
329 |
$85K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
303 |
294 |
$83K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,341 |
1,266 |
$76K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
5,377 |
4,862 |
$75K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,289 |
4,742 |
$63K |
| G0378 |
Hospital observation service, per hour |
1,788 |
820 |
$60K |
| 76801 |
|
202 |
188 |
$56K |
| 73030 |
|
292 |
259 |
$41K |
| 73562 |
|
214 |
204 |
$39K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,518 |
4,102 |
$38K |
| 87088 |
|
7,625 |
7,049 |
$36K |
| 73130 |
|
257 |
243 |
$32K |
| 71045 |
Radiologic examination, chest; single view |
1,629 |
1,468 |
$31K |
| 76641 |
|
104 |
103 |
$29K |
| 72100 |
|
158 |
154 |
$28K |
| 82948 |
|
2,803 |
2,258 |
$27K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
147 |
114 |
$23K |
| 73610 |
|
201 |
181 |
$23K |
| 87070 |
|
780 |
738 |
$21K |
| 81001 |
|
2,801 |
2,520 |
$20K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
118 |
107 |
$19K |
| 73110 |
|
105 |
86 |
$19K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
97 |
90 |
$17K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
577 |
530 |
$17K |
| 81025 |
|
2,493 |
2,323 |
$17K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
331 |
292 |
$16K |
| 77065 |
Tomosynthesis, mammo |
90 |
76 |
$16K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,510 |
16,185 |
$16K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,806 |
1,686 |
$16K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,183 |
2,910 |
$15K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,901 |
1,491 |
$15K |
| 70486 |
|
56 |
55 |
$13K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,189 |
1,043 |
$12K |
| 85610 |
|
3,748 |
3,426 |
$12K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,424 |
1,263 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,961 |
3,314 |
$11K |
| 84702 |
|
2,634 |
2,282 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,768 |
3,225 |
$10K |
| 59025 |
Fetal non-stress test |
689 |
481 |
$10K |
| S0028 |
Injection, famotidine, 20 mg |
64 |
57 |
$9K |
| 74018 |
|
137 |
124 |
$8K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
304 |
286 |
$8K |
| J7510 |
Prednisolone oral, per 5 mg |
47 |
44 |
$8K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
707 |
587 |
$8K |
| 71250 |
|
25 |
25 |
$7K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
530 |
500 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
110 |
97 |
$6K |
| 85027 |
|
2,302 |
1,962 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,498 |
3,369 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
1,333 |
1,233 |
$5K |
| 84439 |
|
1,049 |
1,014 |
$5K |
| 76770 |
|
14 |
14 |
$5K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
363 |
348 |
$5K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
76 |
68 |
$5K |
| 90714 |
|
660 |
621 |
$5K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
16 |
15 |
$5K |
| 93971 |
|
29 |
27 |
$4K |
| 96376 |
|
924 |
746 |
$4K |
| 77080 |
|
12 |
12 |
$4K |
| 76536 |
|
12 |
12 |
$4K |
| 86850 |
|
1,249 |
1,162 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,395 |
1,306 |
$3K |
| 80061 |
Lipid panel |
3,628 |
3,518 |
$3K |
| 82272 |
|
362 |
352 |
$2K |
| 73060 |
|
16 |
13 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
856 |
772 |
$2K |
| 87186 |
|
1,341 |
1,239 |
$2K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
201 |
176 |
$2K |
| G0379 |
Direct admission of patient for hospital observation care |
654 |
581 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
487 |
463 |
$2K |
| 86901 |
|
232 |
213 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,912 |
3,740 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
469 |
399 |
$2K |
| 73590 |
|
13 |
12 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14 |
13 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
133 |
127 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
316 |
262 |
$1K |
| 90715 |
|
210 |
195 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
160 |
154 |
$1K |
| 82553 |
|
2,286 |
2,069 |
$960.15 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
965 |
898 |
$864.86 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
379 |
361 |
$791.63 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
839 |
792 |
$788.10 |
| 87485 |
|
94 |
92 |
$788.10 |
| J2060 |
Injection, lorazepam, 2 mg |
177 |
141 |
$773.08 |
| C9113 |
Injection, pantoprazole sodium, per vial |
132 |
105 |
$764.24 |
| 84484 |
|
4,250 |
3,804 |
$617.38 |
| 82570 |
|
354 |
305 |
$509.65 |
| 86140 |
|
519 |
494 |
$506.50 |
| 84436 |
|
52 |
51 |
$441.76 |
| 82784 |
|
14 |
12 |
$422.07 |
| 83690 |
|
3,437 |
3,030 |
$414.64 |
| 87210 |
|
19 |
19 |
$388.75 |
| J1815 |
Injection, insulin, per 5 units |
61 |
36 |
$375.50 |
| 12001 |
|
13 |
13 |
$375.50 |
| 82550 |
|
2,438 |
2,210 |
$225.28 |
| 83880 |
|
581 |
517 |
$165.61 |
| 85730 |
|
2,271 |
2,085 |
$140.60 |
| 84156 |
|
255 |
206 |
$129.85 |
| 86904 |
|
189 |
147 |
$124.20 |
| 83615 |
|
905 |
769 |
$97.20 |
| 83735 |
|
777 |
683 |
$66.49 |
| 84450 |
|
431 |
403 |
$46.40 |
| 83970 |
|
12 |
12 |
$38.80 |
| 88312 |
|
85 |
84 |
$24.40 |
| 80306 |
|
1,203 |
1,072 |
$23.80 |
| 85652 |
|
1,001 |
932 |
$22.80 |
| 82728 |
|
101 |
92 |
$17.20 |
| 87040 |
|
155 |
135 |
$16.60 |
| 84100 |
|
129 |
115 |
$12.80 |
| 82150 |
|
318 |
299 |
$11.60 |
| 84550 |
|
226 |
174 |
$8.40 |
| 86592 |
|
309 |
294 |
$6.00 |
| A4208 |
Syringe with needle, sterile 3 cc, each |
137 |
130 |
$6.00 |
| A4209 |
Syringe with needle, sterile 5 cc or greater, each |
106 |
100 |
$4.00 |
| 85007 |
|
299 |
264 |
$1.00 |
| 85018 |
|
178 |
174 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
47 |
43 |
$0.00 |
| 85379 |
|
345 |
324 |
$0.00 |
| A4615 |
Cannula, nasal |
271 |
248 |
$0.00 |
| 86803 |
|
13 |
12 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
12 |
12 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
48 |
42 |
$0.00 |
| 82607 |
|
41 |
38 |
$0.00 |
| 83550 |
|
43 |
41 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
18 |
13 |
$0.00 |
| 87340 |
|
82 |
80 |
$0.00 |
| 87912 |
|
94 |
92 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
28 |
26 |
$0.00 |
| 82043 |
|
12 |
12 |
$0.00 |
| 82803 |
|
18 |
16 |
$0.00 |
| J3535 |
Drug administered through a metered dose inhaler |
14 |
13 |
$0.00 |
| 86703 |
|
201 |
191 |
$0.00 |
| 85014 |
|
178 |
174 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
30 |
28 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
26 |
25 |
$0.00 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
28 |
27 |
$0.00 |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
52 |
50 |
$0.00 |
| A7002 |
Tubing, used with suction pump, each |
15 |
14 |
$0.00 |
| 86038 |
|
12 |
12 |
$0.00 |